Trial Search Results

Effect of Ondansetron for Withdrawal Symptoms

We hope to determine whether Ondansetron, an anti-nausea medication, works to help relieve withdrawal symptoms experienced while the patient is being weaned off opioid medications. This medication has shown anecdotal evidence of being affective for the treatment of withdrawal symptoms and we hope to determine whether this is affective.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Drug: Ondansetron and Placebo crossover




Inclusion Criteria:-Over 18 years of age

   - No medical contraindications to medication

   - Able to fulfill research procedures

Exclusion Criteria:-Subjects who are unable to respond to our questionnaires or to stimuli
as required by the experimental protocol will be excluded.

   - Subjects will be excluded if they have a history of significant psychiatric disorders
   that would prevent them from engaging in a treatment program.

   - Participating in other studies that would interfere with the procedures in this study

   - Known or apparent pregnancy

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Rebecca McCue
Not Recruiting